Cyient Limited (CYIENT) announced its financial results for the quarter ended September 30, 2026, showcasing robust performance with revenue up 8.1% QoQ and 15.7% YoY. The EBIT stood at INR 237 crores, marking a 16.8% QoQ growth and a 14.2% EBIT margin.

Revenue and Order Intake

The company’s DET* segment reported revenue at INR 1,664 crores. The Q2 FY27 order intake grew by 20.8% YoY, reflecting strong demand across all key segments.

Profitability and Cash Flow

Cyient DET* PAT reached INR 153 crores, with a QoQ growth of 8.7%. The company also generated INR 214 crores in free cash flow (FCF), with a FCF to PAT conversion rate of 139%.

Sukamal Banerjee, Executive Director and Chief Executive Officer, highlighted the quarter’s achievements, noting the highest-ever Q2 order intake and the successful integration of TAO Digital, which adds depth to the company’s platform software and data engineering capabilities.

Looking ahead, Cyient remains confident in navigating industry headwinds and creating sustainable long-term value for shareholders, driven by strong order books and a maturing pipeline.

Source: NSE Corporate Announcement

Fundamental & Technical Analysis of Cyient Limited

Cyient Limited belongs to the Industrials › Conglomerates sector. Here’s a quick read on where the business and the stock stand today.

Cyient gains 39.9% over three months and trades near its 52-week highs. Thin margins at 5.0% leave limited room for error — any demand softness or cost spike hits the bottom line hard. Revenue contracts at 6.5% CAGR. That signals structural headwinds, not a short-term blip. The stock trades at 94% of its 52-week range — near its best levels of the year. Clearly, the market pays a premium for this name. The stock rises 39.9% in three months on 6.5% revenue growth. As a result, the market gives it more credit than the fundamentals strictly justify. Watch the next quarterly results. If growth accelerates, the move makes sense. If not, expect some gains to unwind. Check Fundamentals of Cyient Limited.

Cyient Limited (CYIENT) has unveiled its Q2 FY27 investor presentation, highlighting sustained growth and strategic investments. The company reported a 50% QoQ increase in order intake for the custom ASIC business, securing a large engagement with a global semiconductor company. Revenue grew 8% QoQ, marking the 6th consecutive quarter of sequential growth. Margins held steady QoQ, as higher volumes absorbed increased wafer costs and investments in R&D and talent. The order book momentum continued for the 6th consecutive quarter, surpassing the previous quarter’s record, with a strong inflows from large OEMs resulting in a book-to-bill ratio of 1.6x.

Strong Demand Momentum

The company continues to invest in R&D in line with its product strategy. High-voltage power products for AI data centers are on track, and these investments are expected to start translating into revenue in the next fiscal year. Memory shortages may slow near-term growth, but the $100 Mn+ ASIC pipeline supports long-term confidence.

Segment Performance

Growth remained positive across key segments, led by Aerospace and Industrial, with Defense and Medical gaining momentum. The Transportation & Mobility segment saw a 16.5% YoY growth, while Networks & Infrastructure and Strategic Units experienced minor declines. TAO Digital continued to show robust performance.

As Cyient Limited (CYIENT) looks ahead, it remains focused on profitable growth and sustainable margin improvement over the medium to long term.

Source: NSE Corporate Announcement

Fundamental & Technical Analysis of Cyient Limited

Cyient Limited belongs to the Industrials › Conglomerates sector. Here’s a quick read on where the business and the stock stand today.

Cyient gains 39.9% over three months and trades near its 52-week highs. Thin margins at 5.0% leave limited room for error — any demand softness or cost spike hits the bottom line hard. Revenue contracts at 6.5% CAGR. That signals structural headwinds, not a short-term blip. The stock trades at 94% of its 52-week range — near its best levels of the year. Clearly, the market pays a premium for this name. The stock rises 39.9% in three months on 6.5% revenue growth. As a result, the market gives it more credit than the fundamentals strictly justify. Watch the next quarterly results. If growth accelerates, the move makes sense. If not, expect some gains to unwind. Check Fundamentals of Cyient Limited.

SRF Limited, an innovation-led materials and chemicals company, announced its consolidated financial results for the second quarter and half year ended September 30, 2026. The company’s unaudited results were approved by the Board of Directors in a meeting held earlier today. The consolidated revenue of the Company increased 35% from ₹3,640 crore to ₹4,904 crore in Q2FY27 when compared with the corresponding period last year (CPLY). The Company’s operational earnings before interest and tax (Operational EBIT) increased 26% from ₹650 crore to ₹816 crore in Q2FY27 when compared with CPLY. The Company’s profit after tax (PAT) increased 31% from ₹388 crore to ₹509 crore in Q2FY27 when compared with CPLY.

Segment Results

The Chemicals Business reported a 25% increase in segment revenue, from ₹1,667 crore to ₹2,079 crore during Q2FY27 compared to CPLY. The Fluorochemicals Business delivered robust refrigerant sales volumes, supported by positive pricing momentum across key products, while maintaining its leadership position across primary markets. The Specialty Chemicals Business navigated a dynamic operating environment shaped by evolving global pricing trends, industry overcapacity in China and ongoing geopolitical developments. The Performance Films & Foil Business reported a 51% increase in segment revenue, from ₹1,408 crore to ₹2,122 crore during Q2FY27 compared to CPLY. The Technical Textiles Business reported a 25% increase in segment revenue, from ₹474 crore to ₹595 crore during Q2FY27 over CPLY.

Capex and Innovation

The Board has approved an investment of approximately ₹600 crore to establish a battery-grade Aluminium foil manufacturing facility in India. The proposed facility, with a total capacity of approximately 12,000 metric tons per annum, will cater to both lithium-ion (Li-ion) and sodium-ion (Na-ion) battery applications, supporting the growing requirements of the energy storage and electric mobility sectors. As of September 30, 2026, the Company has filed a total of 539 patent applications and has been granted 160 patents globally.

Source: NSE Corporate Announcement

Fundamental & Technical Analysis of SRF Limited

SRF Limited belongs to the Industrials › Conglomerates sector. Here’s a quick read on where the business and the stock stand today.

SRF falls 14.0% over three months and has not found a floor yet. Revenue contracts at 1.8% CAGR. That signals structural headwinds, not a short-term blip. No meaningful dividend — total return is entirely dependent on capital appreciation. The stock sits at 14% of its 52-week range, close to annual lows. Historically, value investors build positions at these levels — though cheap stocks can stay cheap. Revenue grows at 1.8% CAGR — a respectable pace. However, the stock drops 14.0% in three months without an obvious fundamental trigger. Sector-wide pressure or a valuation re-rating can persist for longer than expected. Therefore, there is no rush to step in. Check Fundamentals of SRF Limited.